¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sexual life"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sexual activity
    ¼ºÈ°µ¿
  • sexual ambiguity
    ¼ºº°¸ðÈ£
  • sexual arousal disorder
    ¼º(Àû)ÈïºÐÀå¾Ö
  • sexual assault
    ¼ºÆøÇà
  • sexual aversion disorder
    ¼ºÇø¿ÀÀå¾Ö
  • sexual behavior
    ¼ºÀûÇൿ
  • sexual bondage
    ¼º¼Ó¹Ú
  • sexual cell
    Á¾ÀÚ¼¼Æ÷, »ý½Ä¼¼Æ÷
  • sexual cord
    žÆÁ¤¼¼°ü, ¼º»è
  • sexual cycle
    ¼ºÁÖ±â
  • sexual desire
    ¼º¿å
  • sexual desire disorder
    ¼º¿åÀå¾Ö
  • sexual development
    ¼º±â´É¹ß´Þ
  • sexual deviation
    ¼ºµµÂø(Áõ)
  • sexual disinhibition
    ¼ºÀûÅ»¾ïÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sexual ambiguity
    ¼ºº°¸ðÈ£
  • sexual assault
    ¼ºÆøÇà
  • sexual behavior
    ¼ºÇൿ
  • sexual bondage
    ¼º¼Ó¹Ú
  • sexual cell
    (¢¡germ cell) Á¾ÀÚ¼¼Æ÷, ¹è¾Æ¼¼Æ÷, »ý½Ä¼¼Æ÷
  • sexual cord
    žÆÁ¤¼¼°ü
  • sexual cycle
    ¼ºÁÖ±â
  • female sexual arousal disorder
    ¿©¼º¼ºÀûÈïºÐÀå¾Ö
  • hypoactive sexual desire disorder
    ¼º¿å°¨¼Òº´, ¼º¿å°¨¼ÒÀå¾Ö
  • sexual desire
    ¼º¿å
  • sexual development
    ¼º¹ß´Þ, ¼º±â´É¹ß´Þ
  • sexual deviation
    ¼ºµµÂø(Áõ)
  • sexual disinhibition
    ¼ºÅ»¾ïÁ¦
  • sexual disorder
    ¼ºÀå¾Ö
  • sexual drive
    ¼º¿åµ¿
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • life cycle
    »ýȰ»ç, »ýȰÁÖ±â, »ýȰȯ
  • life expectancy
    ¼ö¸í.
  • life form
    »ýȰÇü(Ë×Ì·Ì´).
  • life habit
    »ýȰ½À¼º(ÊÙËàËÛ), »ýȰ½À°ü (ÊÙËàË´).
  • life history
    »ýȰ»ç(Ë×Ì·Ë×).
  • life instinct
    »ýº»´É(ßæÜâÒö),»îº»´É
  • life insurance
    »ý¸íº¸Çè(Ë×ËÎËÓÌ´).
  • life insurance medicine
    »ý¸íº¸ÇèÀÇÇÐ (ÊÙËö̰).
  • life insurance method
    »ý¸íº¸Çè(¹æ)¹ý (ÊÙËÑ).
  • life jacket
    ±¸¸í(Ë´ËÎ)Á¶³¢.
  • life line =telephone counseling
    »ý¸íÀüÈ­, »ý¸í(±¸Á¶)¼±.
  • life phase
    »ýȰ»ó(Ë×Ì·Ë×).
  • life phenomenon
    »ýȰÇö»ó(ÊÙÌ´Ë×).
  • life raft
    ±¸¸í´ë(Ë´ËÎËÀ).
  • life review
    Àλý¹ÝÃß(ìÑßæÚãõÖ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SAI Self-Analysis Inventory; Sexual Arousability Inventory; Social Adequacy Index; suppressor of anchora...
SAR scatter/air ratio; seasonal allergic rhinitis; sexual attitude reassessment; slowly adapting recepto...
SCT secretin; sex chromatin test; sexual compatibility test; sickle-cell trait; sperm cytotoxicity; spin...
SDS same day surgery; school dental services; self-rating depression scale; sensory deprivation syndrome...
SFI Sexual Function Index; Social Function Index
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AQLQ Asthma Quality of Life Questionnaire
BLS Basic Life Support
CELSS Controlled Ecological Life Support System
DLQI Dermatology Life Quality Index
DALY Disability Adjusted Life Year
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • life phase
    »ýȰ»ó
  • life span
    ¼ö¸í
    °³Ã¼ÀÇ »ýÁ¸ ±â°£.
  • life support
    »ý¸í À¯Áö
  • mean life expectancy
    Æò±Õ ¿©¸í
  • quality of life
    »îÀÇ Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
wrongful life In civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born.
(12 Dec 1998)
postnatal life That interval of life after birth; in man, usually divided into periods: neonatal, infancy, childhood, adolescence, and adulthood.
(05 Mar 2000)
half-life 1. <pharmacology> The period over which the concentration of a specified chemical or drug takes to fall to half its original concentration in the specified fluid or blood.
2. <radiobiology> The time required to reduce the amount of a radionuclide to one-half the amount originally present. Physical or radioactive half-life refers to reduction of activity by radioactive decay, biological half-life refers to biological elimination from the body and effective half-life refers to the combined action of radioactive decay and biological elimination.
(16 Dec 1997)
prenatal life That interval of life between conception and birth; in humans, usually divided into embryonic and foetal periods.
(05 Mar 2000)
direct life cycle <epidemiology> A life cycle in which a parasite is transmitted directly from one host to the next without an intermediate host or vector of another species.
(05 Dec 1998)
drug half-life The amount of time it takes for one-half of an administered drug to be lost through biological processes (metabolism and elimination).
(27 Sep 1997)
immediately dangerous to life concentration <radiobiology> This is a regulatory value defined as the maximum exposure concentration in the workplace from which one could escape within 30 minutes without suffering symptoms which would interfere with escaping and without suffering any irreversible health effects.
(04 Nov 1997)
quality adjusted life year A year of life adjusted for its quality or its value. A year in perfect health is considered equal to 1.0 qaly. The value of a year in ill health would be discounted. For example, a year bedridden might have a value equal to 0.5 qaly.
A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services.
(12 Jul 2000)
quality of life Refers to the level of comfort, enjoyment, ability to pursue daily activities. Often used in discussions of treatment options.
(16 Dec 1997)
indirect life cycle <epidemiology> A life cycle which requires one or more intermediate hosts before the definitive host species is reinfected. Compare direct, nondirect.
(05 Dec 1998)
insurance, life Insurance providing for payment of a stipulated sum to a designated beneficiary upon death of the insured.
(12 Dec 1998)
economic value of life The evaluation of the monetary value of a life lost or a life saved.
(12 Dec 1998)
effective half-life <radiobiology> Time required for a radioactive substance contained in a biological system (such as a person or an animal) to reduce its radioactivity by half, as a combination result of radioactive decay and biological elimination from the system.
(09 Oct 1997)
elimination half-life <pharmacology> The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent.
(09 Oct 1997)
expectation of life The average number of years of life an individual of a given age is expected to live if current mortality rates continue to apply; a statistical abstraction based on existing age-specific death rates.
Expectation of life at age x, The average number of additional years a person aged x would live if current mortality trends continue to apply, based on the age-specific death rates for a given year.
Expectation of life at birth, Average number of years of life a newborn baby can be expected to live if current mortality trends continue.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • life net
    (¼Ò¹æ¿ëÀÇ) ±¸¸í¸Á
  • life office
    »ý¸íº¸Çèȸ»ç
  • life peer
    ÀÏ´ë ±ÍÁ·
  • life policy
    »ý¸íº¸ÇèÁõ¼­
  • life preserver
    (¼öÁß) ±¸¸í´ë
  • life science
    »ý¸í°úÇÐ(»ý¹°ÇÐ,»ýÈ­ÇÐ,ÀÇÇÐ,½É¸®ÇÐ µûÀ§)
  • life sentence
    Á¾½ÅÇü;¹«±â¡¿ª
  • life span
    (»ý¸íüÀÇ) ¼ö¸í
  • middle life
    Áß³â;Áß·ùÀÇ »ýȰ
  • natural life
    õ¼ö;õ¸í;¼ö¸í
  • night life
    ¹ãÀÇ À¯Èï;¹ã³îÀÌ
  • product life cycle
    Á¦Ç°ÀÇ ¶óÀÌÇÁ »çÀÌŬ
  • real life
    ½Ç»ýȰ(¼Ò¼³.¿¬±Ø¿¡ ´ëÇØ¼­)
  • real-life
    ½Ç»ýȰ(Çö½Ç)ÀÇ
  • right-to-life
    ÀӽŠÁßÀý¿¡ ¹Ý´ëÇÏ´Â;-lifer ÀӽŠÁßÀý ±ÝÁö¹ý ÁöÁöÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á